Guerbet
36.68
16-五月-24 11:29:10
15 分钟延时
股票
-0.33
-0.88%
今日范围
36.45 - 36.90
ISIN
FR0000032526
来源
Cboe
-
25 4月 2024 11:45:00 条件 Nasdaq GlobeNewswire
-
Guerbet: Financial agenda for 2024
15 1月 2024 12:00:00 条件 Nasdaq GlobeNewswire
-
GUERBET : Revenue at 30 September 2023.
19 10月 2023 11:45:00 条件 Nasdaq GlobeNewswire
-
Guerbet: CHMP positive opinion
12 10月 2023 11:57:24 条件 Nasdaq GlobeNewswire
-
Guerbet: 2023 half-year results
20 9月 2023 11:45:00 条件 Nasdaq GlobeNewswire
-
Guerbet: First-half 2023 revenue
20 7月 2023 11:46:36 条件 Nasdaq GlobeNewswire
-
Guerbet: Guerbet wins PI-CAI Grand Challenge on detection of prostate cancer
17 7月 2023 13:00:19 条件 Nasdaq GlobeNewswire
-
10 7月 2023 11:48:16 条件 Nasdaq GlobeNewswire
-
Guerbet: Changes in Guerbet's Board of Directors
26 5月 2023 11:29:04 条件 Nasdaq GlobeNewswire
-
20 4月 2023 11:49:25 条件 Nasdaq GlobeNewswire
-
22 3月 2023 12:45:58 条件 Nasdaq GlobeNewswire
-
09 2月 2023 11:46:34 条件 Nasdaq GlobeNewswire
-
Guerbet: 2023 Strategic Priorities
16 1月 2023 12:40:42 条件 Nasdaq GlobeNewswire
-
11 1月 2023 13:46:47 条件 Nasdaq GlobeNewswire
-
Guerbet: Guerbet announces a change in governance for its Artificial Intelligence projects
03 11月 2022 13:04:18 条件 Nasdaq GlobeNewswire
-
Guerbet: Revenue at September 30, 2022
20 10月 2022 11:45:00 条件 Nasdaq GlobeNewswire
-
Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem™ (Gadopiclenol)
21 9月 2022 13:00:00 条件 Nasdaq GlobeNewswire
-
Guerbet: 2022 half-year results
21 9月 2022 11:45:00 条件 Nasdaq GlobeNewswire
-
Guerbet: Revenue at June 30, 2022
21 7月 2022 11:45:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >